Company Filing History:
Years Active: 2022
Title: Thomas Mark Tremblay: Innovator in Onychomycosis Treatment
Introduction
Thomas Mark Tremblay is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medical treatments, particularly focusing on onychomycosis, a fungal infection affecting the nails. His innovative approach has led to the development of effective treatment compositions and methods.
Latest Patents
Tremblay holds a patent for "Onychomycosis treatment compositions and methods." This patent presents compositions and methods that provide substantially improved physical and pharmacological parameters for subungually administrable formulations. The formulations are designed to retain liquid in sufficient quantities and penetrate the polysaccharide matrix commonly associated with onychomycosis. The carrier is formulated to have a high concentration of the active pharmaceutical ingredient (API), allowing migration within the subungual space while reducing systemic absorption and promoting diffusion of the API into the nail plate.
Career Highlights
Tremblay is currently associated with Hallux Inc., where he continues to innovate in the field of nail treatment. His work has been instrumental in advancing the understanding and treatment of onychomycosis, providing patients with more effective options.
Collaborations
Some of his notable coworkers include Christopher Ronald Agee and Robert L Orr. Their collaboration has contributed to the development of advanced treatment methods in the field.
Conclusion
Thomas Mark Tremblay's contributions to onychomycosis treatment highlight his innovative spirit and dedication to improving patient care. His work continues to influence the medical field positively.